| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |